NCT07086430

Brief Summary

It was VAT volume predict patient outcome, while VAT density predicted baseline membrane function in PD patients and reflected peritoneal vascular density and local inflammation status.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
358

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2015

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 21, 2015

Completed
8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 11, 2023

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 14, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 25, 2025

Completed
Last Updated

July 25, 2025

Status Verified

April 1, 2025

Enrollment Period

8 years

First QC Date

July 14, 2025

Last Update Submit

July 24, 2025

Conditions

Keywords

peritoneal dialysisfat attenuation index on CT

Outcome Measures

Primary Outcomes (1)

  • To evaluate the association between peritoneal membrane solute transfer rate and abdominal visceral adipose tissue density measured on CT

    from the baseline, 4 weeks before PD catheter insert surgery until patients quit PD or follow up up to 48 months

Study Arms (1)

derivation cohort; validation cohort

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study included peritoneal dialysis patients follow up in our center who had an abdominal CT scan within 2 weeks before PD catheter incubation. Those with acute inflammation according to clinical signs, lab results or abdominal CT scan were excluded from the cohort. In early years, abdominal CT scan was done if the patient reported history of abdominal abnormalities, such as history of cholelithiasis. Since 2020 it became a routine check before PD catheter incubation in our center. Those with cholelithiasis or hernia were suggested to had the preventive operation at the time of PD catheter incubation under general anesthesia. The patients started PD within 4 weeks after catheter incubation. A validation cohort was from a satellite center of the hospital. The inclusion criteria were same as the derivation cohort.

You may qualify if:

  • The study included peritoneal dialysis patients follow up in our center who had an abdominal CT scan within 2 weeks before PD catheter incubation.

You may not qualify if:

  • Those with acute inflammation according to clinical signs, lab results or abdominal CT scan were excluded from the cohort.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Uremia

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

July 14, 2025

First Posted

July 25, 2025

Study Start

July 21, 2015

Primary Completion

July 11, 2023

Study Completion

May 1, 2025

Last Updated

July 25, 2025

Record last verified: 2025-04